A novel small molecule inhibitor of hepatitis C virus entry - Test2 - elhamkhani - TriplyDB

A novel small molecule inhibitor of hepatitis C virus entry

A novel small molecule inhibitor of hepatitis C virus entry

http://www.wikidata.org/entity/Q28475468

about

Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81 Nanostructures for the Inhibition of Viral Infections Neutralizing antibody response to hepatitis C virus An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission The novel immunosuppressive protein kinase C inhibitor sotrastaurin has no pro-viral effects on the replication cycle of hepatitis B or C virus High-throughput screening and rapid inhibitor triage using an infectious chimeric Hepatitis C virus Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Novel approaches in anti-arenaviral drug development Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine.Hepatitis C treatment: current and future perspectives A human claudin-1-derived peptide inhibits hepatitis C virus entry.Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.Hepatitis C viral entry inhibitors prolong viral suppression by replication inhibitors in persistently-infected Huh7 cultures Characterization of HCV genotype 5a envelope proteins: implications for vaccine development and therapeutic entry target.Griffithsin has antiviral activity against hepatitis C virus Requirement for chloride channel function during the hepatitis C virus life cycle.Tannic Acid Inhibits Hepatitis C Virus Entry into Huh7.5 Cells Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus Characterization of hepatitis C virus recombinants with chimeric E1/E2 envelope proteins and identification of single amino acids in the E2 stem region important for entry Development of novel entry inhibitors targeting emerging viruses.Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA.Current and future therapies for hepatitis C virus infection: from viral proteins to host targets.Abl Tyrosine Kinase Regulates Hepatitis C Virus Entry A small-molecule inhibitor of hepatitis C virus infectivity.Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.(-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.ANALYSIS OF POLYMORPHISMS IN THE INTERLEUKIN 18 GENE PROMOTOR (-137 G/C AND -607 C/A) IN PATIENTS INFECTED WITH HEPATITIS C VIRUS FROM THE BRAZILIAN AMAZON.(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.Chemical genetics-based development of small molecules targeting hepatitis C virus.Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle.A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.Discovery of Imidazo[1,2-α][1,8]naphthyridine Derivatives as Potential HCV Entry Inhibitor.Sustained virological response rates to antiviral therapy in genotype 1 and 3 chronic hepatitis C patients: a study from north India.Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry.Inhibitors of hepatitis C virus entry may be potent ingredients of optimal drug combinations.Current and future targets of antiviral therapy in the hepatitis C virus life cycle Blocking HCV entry as potential antiviral therapy

P2860

Q24598370-09572E22-6033-48C0-95F2-0739A8FDFCF0 Q26801513-68F4D66D-4AEB-41E9-B219-AD7DF582BF51 Q27027484-6844FF8F-E645-4C63-9E70-0CCA581A5AA7 Q27684354-EAEDC233-7969-41B1-A637-502A3BC6E7BA Q28476762-E1CFA9AA-1155-4957-B8B9-40AB36A33480 Q28482091-D28B204A-36BE-4339-8381-340331D69B2C Q28482494-20A68CBB-2762-4D73-8122-1AE0FECD3657 Q30386551-F19F1DA7-2169-430C-BCCC-AF48A6BA1208 Q33779739-7BAA45C5-C8D7-463A-A886-E19D96E67129 Q33797817-0AA33649-BE54-4679-BDD7-C6596885860B Q34147323-CA04BE94-6D20-467A-A482-770E3BDB1242 Q34179353-E6B3914B-78FD-43E5-8E23-D4B0A284247E Q34636137-92F396C0-05F6-4ED4-BC36-D57D795AF79E Q34766299-0B2C5594-72C1-45AC-8E4C-4AFBB1A18682 Q34864567-40E10DD6-C011-4675-AA98-7A08E48B71EA Q35363633-3B23918D-B82F-4DCA-AAE1-D37BE1D46CE9 Q35488072-988857B5-1FF2-4A0D-9E49-C90F57F9F9A9 Q35695028-E1A5B1BC-2A61-45D0-BAEE-98229EE471A7 Q36080826-1187476F-9E53-441F-8DF5-4DCC5D62EDE5 Q36559862-8C147B9D-11D5-4062-B653-85E9DA08D8BE Q36655280-5B51EB9D-AF92-421D-BF48-C0B0F6EAB8DD Q37533386-A30AA6FB-04C5-42E2-8E06-AA86833EE0B6 Q38131681-43A4A1DA-DE5F-4884-B728-FFE1BFB59E67 Q38695072-B9A4F040-EBB6-47DF-8A21-A7EFF2990B64 Q39069509-75F16B7C-654C-46C9-BB2C-827A7AF495C8 Q39117420-5647ADEB-96F1-4323-B9E0-27C69171B010 Q39366534-DE805A3F-8A8F-4D17-9D9E-C965F5F3E483 Q39430001-E4CE3485-2134-4B55-9B1B-84C8C7E4EF2A Q39439105-262395E2-694E-42D1-98B9-4E8EFC15DC22 Q39491188-2D2B3740-52CC-4303-A380-9B7447EDA49F Q39532092-CF0FF0F9-C90A-4245-9E89-BB8129F94B45 Q40063790-B7EF7E60-3494-406B-962A-899F15C2D1C0 Q40151324-08693833-BD33-43D2-8E14-CDFE25E15668 Q40278524-26675065-B323-470F-A892-B82EE096D994 Q40986696-174EB5B0-77CC-4251-AE4B-C1B1E7AF39EA Q41257949-FA9EBB87-5A80-4ABE-8190-C464443E870D Q42772176-2837CF89-6824-4DBA-AF9B-592B8131FFA0 Q45328861-F926D9AE-579A-4EB1-80F3-C20B860AF91F Q57071775-5E368701-B48C-47A2-85AA-F571472E16CD Q57241788-442750A7-B8D0-4CB7-825D-B84E098ED5FE

P2860

A novel small molecule inhibitor of hepatitis C virus entry

http://www.wikidata.org/entity/Q28475468

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

A novel small molecule inhibitor of hepatitis C virus entry

@ast

A novel small molecule inhibitor of hepatitis C virus entry

@en

A novel small molecule inhibitor of hepatitis C virus entry

@nl

type

label

A novel small molecule inhibitor of hepatitis C virus entry

@ast

A novel small molecule inhibitor of hepatitis C virus entry

@en

A novel small molecule inhibitor of hepatitis C virus entry

@nl

prefLabel

A novel small molecule inhibitor of hepatitis C virus entry

@ast

A novel small molecule inhibitor of hepatitis C virus entry

@en

A novel small molecule inhibitor of hepatitis C virus entry

@nl

P1433

Q28475468-489E8F62-132F-43AF-892E-EC943DDE8EEC

P1476

Q28475468-EA8A3D11-A93E-4216-9573-4F012B9351A7

P2093

Q28475468-052EA810-041F-4C83-81F2-A41E2064CA5C

Q28475468-0D074841-40EF-4AA0-8193-6B5DF1EA835B

Q28475468-1220DFA7-4C7F-436A-875A-A8C84E7844DA

Q28475468-13077943-2EA5-4901-8204-36A90C60450D

Q28475468-3935BB32-89C2-4405-A5F9-A5D4EBC5F1D8

Q28475468-42659D21-25F0-4F53-882B-D3EE6BD4586F

Q28475468-4744E6BB-79BE-4189-8DFF-3E6F27AA9AC5

Q28475468-479CF403-5F28-4E6B-A52D-9974D9A4E8B7

Q28475468-5C58B1EE-D915-4E79-B2D7-212276B45D49

Q28475468-6BF30FD2-8F2D-479F-9226-CDC9D8301DA1

P2860

Q28475468-003E095F-A066-4191-96EB-4202DA50DF31

Q28475468-08740B20-742F-475E-AF62-45F162BDF8B2

Q28475468-08CAE9C7-D538-430A-B47E-C7CD7B5ACB94

Q28475468-09B9DF23-C6F0-4AB2-A885-387B7C40C263

Q28475468-0C8FA3B5-A1CD-4826-9F86-7178AAC8AF78

Q28475468-18F73A71-096E-4F26-BB01-065F748A712A

Q28475468-22FEB616-C9CF-4CC3-AFF0-0CEF76D0B495

Q28475468-25197154-7D88-4AFF-AC12-5D4B69868812

Q28475468-26C588F3-8144-496A-A10F-C8E3D9EE1868

Q28475468-2DEDBAC8-1AA2-4ED3-BAFE-53D6F487D089

P304

Q28475468-88A69F6B-0BE0-42D1-8969-CB3707E4DAD1

P31

Q28475468-05A8E308-6161-4E10-A076-3920BF7159BF

P356

Q28475468-99D5BA1A-BA2D-4E02-8475-CCDAEA5F8CB3

P407

Q28475468-093AC9CC-30C9-447C-96EF-74EE85B4DF36

P433

Q28475468-90E1D788-6E75-4199-95B4-FC64A5115920

P478

Q28475468-4AF12238-A2E3-49B1-A396-E7CAD3F330AC

P577

Q28475468-F9C0D463-01CC-4CD8-BAD8-C6F19C072688

P5875

Q28475468-2204A7FD-98AC-4ECA-AA08-D0949237549A

P698

Q28475468-179665F9-91F6-410F-9D8F-173350C4D2D4

P932

Q28475468-F765902A-6008-47CB-98DF-75765D249656

P356

JOURNAL.PPAT.1001086

P1433

P1476

A novel small molecule inhibitor of hepatitis C virus entry

@en

P2093

Ann W Walsh

http://www.w3.org/2001/XMLSchema#string

Annapurna Pendri

http://www.w3.org/2001/XMLSchema#string

Betsy J Eggers

http://www.w3.org/2001/XMLSchema#string

Carl J Baldick

http://www.w3.org/2001/XMLSchema#string

Charles E Mazzucco

http://www.w3.org/2001/XMLSchema#string

Daniel J Tenney

http://www.w3.org/2001/XMLSchema#string

Guangzhi Zhai

http://www.w3.org/2001/XMLSchema#string

Jie Fang

http://www.w3.org/2001/XMLSchema#string

Kevin A Pokornowski

http://www.w3.org/2001/XMLSchema#string

Mark I Cockett

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains

Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus

A small-molecule dengue virus entry inhibitor

Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I

Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus

Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein.

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

P304

e1001086

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1001086

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46256392

http://www.w3.org/2001/XMLSchema#string

P698

20838466

http://www.w3.org/2001/XMLSchema#string

P932

2936744

http://www.w3.org/2001/XMLSchema#string